Definition
Sphingolipids (SLDs) contain sphingosine (Sph) or a similar moiety. Sphingosine (Fig. 1a) is D-erythro-trans-4-octadecene-2-amino-1,3-diol; R1 is typically a C13 alkyl chain. Ceramide or Cer (Fig. 1b) is a fatty acid amide of sphingosine that plays a pivotal role in cell growth and death, in which R2 symbolizes a saturated or monoenoic fatty acid containing 16–32 or more carbon atoms. Some fatty acids have an OH at carbon-2 or at the end carbon. Some ceramides contain phytosphingosine instead of Sph; here the double bond is replaced by an OH at C-4.
This is a preview of subscription content, log in via an institution.
References
Hakomori SI (2008) Structure and function of glycosphingolipids and sphingolipids: recollections and future trends. Biochim Biophys Acta 1780:325–346
Li R, Ladisch S (1996) Abrogation of shedding of immunosuppressive neuroblastoma gangliosides. Cancer Res 56:4602–4605
Ogretmen B, Hannun YA (2004) Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 4:604–616
Panjarian S, Kozhaya L, Arayssi S, Yehia M, Bielawski J, Bielawska A, Usta J, Hannun YA, Obeid LM, Dbaibo GS (2008) De novo N-palmitoylsphingosine synthesis is the major biochemical mechanism of ceramide accumulation following p53 up-regulation. Prostaglandins Lipid Mediat 86:41–48
Radin NS (2004) Sphingolipids as coenzymes in anion transfer and tumor death. Bioorg Med Chem 12:6029–6037
Radin NS (2007) Allylic structures in body and cancer drugs that control cell life and death. Expert Opin Drug Discov 2:1–13
Ruvolo PP (2003) Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol Res 47:383–392
Yin J, Miyazaki K, Shaner RL, Merrill AH Jr, Kannagi R (2010) Altered sphingolipid metabolism induced by tumor hypoxia – new vistas in glycolipid tumor markers. FEBS Lett 584:1872–1878
See Also
(2012) AKT. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 115. doi: 10.1007/978-3-642-16483-5_163
(2012) Allylic Structures. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 143. doi: 10.1007/978-3-642-16483-5_202
(2012) D-MAPP. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1128. doi: 10.1007/978-3-642-16483-5_1659
(2012) Ganglioside Secretion. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1495. doi: 10.1007/978-3-642-16483-5_2321
(2012) Gaucher Disease. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1515. doi: 10.1007/978-3-642-16483-5_2340
(2012) Glutathione. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1559. doi: 10.1007/978-3-642-16483-5_2438
(2012) Histone Acetylation. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 1697. doi: 10.1007/978-3-642-16483-5_2750
(2012) Multidrug Resistance. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2393. doi: 10.1007/978-3-642-16483-5_3887
(2012) PDMP. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, pp 2804–2805. doi: 10.1007/978-3-642-16483-5_4427
(2012) Poly-Drug Chemotherapy. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 2954. doi: 10.1007/978-3-642-16483-5_4657
(2012) Rafts. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3163. doi: 10.1007/978-3-642-16483-5_4938
(2012) S1P. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3327. doi: 10.1007/978-3-642-16483-5_5136
(2012) Sphinganine. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3480. doi: 10.1007/978-3-642-16483-5_5437
(2012) Sphingolipids. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, pp 3484–3485. doi: 10.1007/978-3-642-16483-5_5439
(2012) Sphingomyelins. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3485. doi: 10.1007/978-3-642-16483-5_5441
(2012) Sphingosine. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3485. doi: 10.1007/978-3-642-16483-5_5442
(2012) Sulfatide. In: Schwab M (ed) Encyclopedia of Cancer, 3rd edn. Springer Berlin Heidelberg, p 3556. doi: 10.1007/978-3-642-16483-5_5563
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Radin, N.S. (2014). Sphingolipid Metabolism. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_5438-5
Download citation
DOI: https://doi.org/10.1007/978-3-642-27841-9_5438-5
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-27841-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences